It's understandable to feel concerned when you notice a number creeping up, even when overall bloodwork looks stable. Beta-2 microglobulin (B2M) is a protein that can rise with myeloma activity in the bone marrow, and a level of 4.73 mg/L is worth paying attention to — though it doesn't automatically mean things are Show Full Answer
It's understandable to feel concerned when you notice a number creeping up, even when overall bloodwork looks stable. Beta-2 microglobulin (B2M) is a protein that can rise with myeloma activity in the bone marrow, and a level of 4.73 mg/L is worth paying attention to — though it doesn't automatically mean things are progressing.
Here's what B2M levels generally indicate in myeloma staging:
- Below 3.5 mg/L — associated with earlier/less advanced disease
- 3.5–5.5 mg/L — falls in a middle range (stage 2 territory)
- 5.5 mg/L or higher — associated with more advanced disease (stage 3)
A slowly rising B2M, even with otherwise stable results, can sometimes signal that myeloma activity is gradually increasing. However, B2M doesn't tell the whole story on its own. Doctors typically look at B2M alongside other markers, including:
- LDH levels (lactate dehydrogenase)
- Albumin levels
- M protein levels
- Cytogenetic (genetic) test results
Since you're being treated for high-risk smoldering myeloma, it's really important to bring this trend to your care team's attention right away. A slow rise may prompt them to reassess your treatment plan or run additional tests to get a clearer picture.
10 hours ago
Join
Your Privacy Choices
